ATE449163T1 - Verfahren zur gewinnung von muskelnabstammenden zellpopulationen und deren verwendung - Google Patents

Verfahren zur gewinnung von muskelnabstammenden zellpopulationen und deren verwendung

Info

Publication number
ATE449163T1
ATE449163T1 AT01943584T AT01943584T ATE449163T1 AT E449163 T1 ATE449163 T1 AT E449163T1 AT 01943584 T AT01943584 T AT 01943584T AT 01943584 T AT01943584 T AT 01943584T AT E449163 T1 ATE449163 T1 AT E449163T1
Authority
AT
Austria
Prior art keywords
cell
cell populations
preparing
derived cell
culture
Prior art date
Application number
AT01943584T
Other languages
English (en)
Inventor
Jean-Thomas Vilquin
Jean-Pierre Marolleau
Jacques Tremblay
Isabelle Robert
Brigitte Ternaux
Original Assignee
Assist Publ Hopitaux De Paris
Inst Nat Sante Rech Med
Ass Fr Contre Les Myopathies
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Assist Publ Hopitaux De Paris, Inst Nat Sante Rech Med, Ass Fr Contre Les Myopathies filed Critical Assist Publ Hopitaux De Paris
Application granted granted Critical
Publication of ATE449163T1 publication Critical patent/ATE449163T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0658—Skeletal muscle cells, e.g. myocytes, myotubes, myoblasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Neurology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Adornments (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT01943584T 2000-06-07 2001-06-07 Verfahren zur gewinnung von muskelnabstammenden zellpopulationen und deren verwendung ATE449163T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0007304A FR2810045B1 (fr) 2000-06-07 2000-06-07 Procede d'obtention de population cellulaires caracterisees d'origine musculaire et utilisations
PCT/FR2001/001768 WO2001094555A1 (fr) 2000-06-07 2001-06-07 Procede d'obtention de populations cellulaires caracterisees d'origine musculaire et utilisations

Publications (1)

Publication Number Publication Date
ATE449163T1 true ATE449163T1 (de) 2009-12-15

Family

ID=8851058

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01943584T ATE449163T1 (de) 2000-06-07 2001-06-07 Verfahren zur gewinnung von muskelnabstammenden zellpopulationen und deren verwendung

Country Status (14)

Country Link
US (3) US20040043008A1 (de)
EP (1) EP1292671B9 (de)
JP (1) JP2003535586A (de)
AT (1) ATE449163T1 (de)
AU (2) AU6612701A (de)
BR (1) BR0111497A (de)
CA (1) CA2411762A1 (de)
CY (1) CY1109745T1 (de)
DE (1) DE60140536D1 (de)
DK (1) DK1292671T3 (de)
ES (1) ES2335747T3 (de)
FR (1) FR2810045B1 (de)
PT (1) PT1292671E (de)
WO (1) WO2001094555A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1272204E (pt) * 2000-04-14 2007-10-02 Univ Pittsburgh Aumento e enchimento de tecidos moles e osso utilizando células progenitoras derivadas de músculo, suas composições e tratamentos
FR2810045B1 (fr) * 2000-06-07 2004-09-03 Assist Publ Hopitaux De Paris Procede d'obtention de population cellulaires caracterisees d'origine musculaire et utilisations
MXPA04011043A (es) * 2002-05-10 2005-02-14 Isolagen Technologies Inc Tratamientos con fibrolasto antologo.
US9617516B2 (en) * 2003-04-25 2017-04-11 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Muscle-derived cells (MDCs) for promoting and enhancing nerve repair and regeneration
WO2006006692A1 (ja) * 2004-07-08 2006-01-19 Japan Science And Technology Agency 低血清培養で選択的に増殖する動物組織遍在性の分化多能性細胞
FR2890977A1 (fr) * 2005-09-19 2007-03-23 Assist Publ Hopitaux De Paris Procede d'obtention de cellules musculaires lisses humaines et leurs applications
FR2909559B1 (fr) * 2006-12-06 2012-09-07 Inst Vaisseaux Et Du Sang Preparations cellulaires pour une utilisation comme agent stimulant la revascularisation
AU2008263134B2 (en) * 2007-05-29 2014-06-19 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Bone augmentation utilizing muscle-derived progenitor compositions, and treatments thereof
EP2206774A1 (de) 2008-12-23 2010-07-14 Genzyme Corporation Von Muskeln stammende Zellen mit Differenzierungsfähigkeiten
CN102712897B (zh) * 2009-07-09 2018-07-10 詹森生物科技公司 心脏组织来源细胞
FR3074018B1 (fr) 2017-11-27 2020-09-11 Lab Francais Du Fractionnement Procede de cryoconservation de cellules a visee therapeutique
FR3088541B1 (fr) 2018-11-15 2021-11-05 Lab Francais Du Fractionnement Procede de conservation de cellules a visee therapeutique
WO2020243543A1 (en) * 2019-05-31 2020-12-03 Figene, Llc Fibroblast therapy for treatment of duchenne muscular dystrophy
EP4026587A4 (de) * 2019-09-30 2022-11-16 TERUMO Kabushiki Kaisha Verfahren zur erhöhung des anteils an cd56+-zellen

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5143842A (en) * 1988-11-01 1992-09-01 The University Of Colorado Foundation, Inc. Media for normal human muscle satellite cells
US5538722A (en) * 1989-06-13 1996-07-23 Stanford University Isolation, growth, differentiation and genetic engineering of human muscle cells
US5574205A (en) * 1989-07-25 1996-11-12 Cell Genesys Homologous recombination for universal donor cells and chimeric mammalian hosts
DK0412700T3 (da) * 1989-08-03 1998-04-06 Univ California Fremgangsmåde til isolering af føtale cytrophoblastceller
US5061620A (en) * 1990-03-30 1991-10-29 Systemix, Inc. Human hematopoietic stem cell
US5196315A (en) * 1990-05-01 1993-03-23 The Johns Hopkins University Human neuronal cell line
AU2593192A (en) * 1992-09-14 1994-04-12 Oystein Fodstad Detection of specific target cells in specialized or mixed cell population and solutions containing mixed cell populations
DE69430846T2 (de) * 1993-08-27 2003-01-16 Dana Farber Cancer Inst Inc Für natürliche killerzellen spezifische antigene und sie identifizierende antikörper
US6110459A (en) * 1997-05-28 2000-08-29 Mickle; Donald A. G. Transplants for myocardial scars and methods and cellular preparations
CA2324350A1 (en) * 1998-03-23 1999-09-30 Zymogenetics, Inc. Cardiac-derived stem cells
ATE369141T1 (de) * 1998-05-01 2007-08-15 Univ Pittsburgh Zellvermittelte genverabreichung durch verwendung von aus muskeln derivierten zellen zur behandlung der knochen-verwandten verletzung oder störung
US7368420B1 (en) * 1998-10-02 2008-05-06 Caritas St. Elizabeth's Medical Center Of Boston, Inc. Akt compositions for enhancing survival of cells
CA2378643A1 (en) * 1999-07-23 2001-02-01 Diacrin, Inc. Muscle cells and their use in cardiac repair
US20030113301A1 (en) * 1999-07-23 2003-06-19 Albert Edge Muscle cells and their use in cardiac repair
FR2810045B1 (fr) * 2000-06-07 2004-09-03 Assist Publ Hopitaux De Paris Procede d'obtention de population cellulaires caracterisees d'origine musculaire et utilisations

Also Published As

Publication number Publication date
CY1109745T1 (el) 2014-09-10
AU6612701A (en) 2001-12-17
US20060088508A1 (en) 2006-04-27
CA2411762A1 (fr) 2001-12-13
EP1292671A1 (de) 2003-03-19
ES2335747T3 (es) 2010-04-05
PT1292671E (pt) 2010-02-05
BR0111497A (pt) 2004-04-06
FR2810045B1 (fr) 2004-09-03
EP1292671B9 (de) 2010-05-19
AU2001266127B2 (en) 2007-01-04
DE60140536D1 (de) 2009-12-31
US20110014159A1 (en) 2011-01-20
US20040043008A1 (en) 2004-03-04
JP2003535586A (ja) 2003-12-02
WO2001094555A1 (fr) 2001-12-13
EP1292671B1 (de) 2009-11-18
DK1292671T3 (da) 2010-03-15
FR2810045A1 (fr) 2001-12-14

Similar Documents

Publication Publication Date Title
CY1109745T1 (el) Μεθοδος ληψης χαρακτηρισμενων πληθυσμων κυτταρου λαμβανομενων απο μυ και χρησεις
Chan et al. Identification of the human skeletal stem cell
Chen et al. Human umbilical cord-derived mesenchymal stem cells do not undergo malignant transformation during long-term culturing in serum-free medium
ATE365793T1 (de) Verfahren zur isolierung und kulturexpansion mesenchymaler stamm-/vorläuferzellen aus nabelschnurblut sowie verfahren zur differenzierung von aus nabelschnurblut stammenden mesenchymalen stamm-/vorläuferzellen in unterschiedliche mesenchymgewebe
NZ333830A (en) Method for assessing chemosensitivity of a biopsy sample
ATE430807T1 (de) Verfahren zur kultivierung von circovirus
ATE312168T1 (de) Verfahren zur kultivierung von krebszellen aus humangewebe und vorrichtung zur aufbereitung von gewebeproben
EP0682107A2 (de) Verfahren zur Langzeitkultur der dermalen Papillezellen
WO2002083864A3 (en) Methods and reagents for cell transplantation
ATE479743T1 (de) Verfahren zur herstellung von zellkulturen aus biologischen präparaten für chemotherapeutische und andere assays
CN110475855A (zh) 用于从牙髓组织衍生的细胞制备牙髓干细胞的方法
ATE361469T1 (de) Methoden zur introduktion heterologer zellen in fische
HUP0302600A2 (hu) Eljárás petefészektüszők in vitro tenyésztésére
DE60038630D1 (de) Verfahren zur ex vivo bildung von säugetier-knochen und dessen verwendungen
Silvério et al. Stem cells: potential therapeutics for periodontal regeneration
DE69714775T2 (de) Verfahren zur Tötung von Zielzellen in geernteten Zellpopulationen mit Hilfe von zwei Immunotoxinen
ATE256120T1 (de) Reagentien für cyp2d fluoreszenztest
AU7345500A (en) Identification of the domain of plasmodium falciparum erythrocyte membrane protein 1 (pfemp1) that mediates adhesion to chondroitin sulfate
FR2848565B1 (fr) Lignee de cellules dendritiques gen2.2
JP2020063192A (ja) 真皮線維芽細胞の培養上清液を含む化粧用組成物およびその製造方法
EP1270719A3 (de) Hemangioblasten enthaltender Zellverband und dessen Herstellungsverfahren
IL165250A (en) Methods of isolating cd 34 negative precursor endothelial cells from a biological sample
JP2008289734A (ja) 骨芽細胞−基材複合体の作製方法
ATE313622T1 (de) Verfahren zur züchtung von haftenden tierischen zellen
Selenko et al. CHARACTERIZATION AND EXPRESSION OF NEURONAL MARKERS IN MESENCHYMAL STROMAL CELLS FROM EXFOLIATED DECIDUOUS TEETH

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1292671

Country of ref document: EP